220 related articles for article (PubMed ID: 10066777)
1. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
Ancsin JB; Kisilevsky R
J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
[TBL] [Abstract][Full Text] [Related]
2. Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A.
Ancsin JB; Kisilevsky R
Amyloid; 1999 Mar; 6(1):37-47. PubMed ID: 10211410
[TBL] [Abstract][Full Text] [Related]
3. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
[TBL] [Abstract][Full Text] [Related]
4. A unique amyloidogenic apolipoprotein serum amyloid A (apoSAA) isoform expressed by the amyloid resistant CE/J mouse strain exhibits higher affinity for macrophages than apoSAA1 and apoSAA2 expressed by amyloid susceptible CBA/J mice.
Liang J; Elliott-Bryant R; Hajri T; Sipe JD; Cathcart ES
Biochim Biophys Acta; 1998 Oct; 1394(1):121-6. PubMed ID: 9767146
[TBL] [Abstract][Full Text] [Related]
5. Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene.
Gonnerman WA; Elliott-Bryant R; Carreras I; Sipe JD; Cathcart ES
J Exp Med; 1995 Jun; 181(6):2249-52. PubMed ID: 7760010
[TBL] [Abstract][Full Text] [Related]
6. Degradation of serum amyloid A in amyloid-susceptible and amyloid-resistant mouse strains.
Elliott-Bryant R; Liang JS; Sipe JD; Cathcart ES
Scand J Immunol; 1996 Sep; 44(3):223-8. PubMed ID: 8795715
[TBL] [Abstract][Full Text] [Related]
7. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells.
Liang JS; Schreiber BM; Salmona M; Phillip G; Gonnerman WA; de Beer FC; Sipe JD
J Lipid Res; 1996 Oct; 37(10):2109-16. PubMed ID: 8906588
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.
Elimova E; Kisilevsky R; Ancsin JB
FASEB J; 2009 Oct; 23(10):3436-48. PubMed ID: 19549924
[TBL] [Abstract][Full Text] [Related]
9. Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A.
Ancsin JB; Kisilevsky R
J Biol Chem; 1997 Jan; 272(1):406-13. PubMed ID: 8995276
[TBL] [Abstract][Full Text] [Related]
10. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
12. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products.
Hoffman JS; Ericsson LH; Eriksen N; Walsh KA; Benditt EP
J Exp Med; 1984 Feb; 159(2):641-6. PubMed ID: 6693836
[TBL] [Abstract][Full Text] [Related]
13. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
Kisilevsky R; Szarek WA
J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
[TBL] [Abstract][Full Text] [Related]
14. Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide.
Drake SL; Klein DJ; Mickelson DJ; Oegema TR; Furcht LT; McCarthy JB
J Cell Biol; 1992 Jun; 117(6):1331-41. PubMed ID: 1607392
[TBL] [Abstract][Full Text] [Related]
15. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95).
Raboudi N; Julian J; Rohde LH; Carson DD
J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862
[TBL] [Abstract][Full Text] [Related]
16. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
Park K; Verchere CB
J Biol Chem; 2001 May; 276(20):16611-6. PubMed ID: 11145957
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux.
Liang JS; Sipe JD
J Lipid Res; 1995 Jan; 36(1):37-46. PubMed ID: 7706946
[TBL] [Abstract][Full Text] [Related]
18. SAA, an apoprotein of HDL: its structure and function.
Benditt EP; Hoffman JS; Eriksen N; Parmelee DC; Walsh KA
Ann N Y Acad Sci; 1982; 389():183-9. PubMed ID: 7046575
[TBL] [Abstract][Full Text] [Related]
19. A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: significance for malarial sporozoite attachment to hepatocytes.
Ancsin JB; Kisilevsky R
J Biol Chem; 2004 May; 279(21):21824-32. PubMed ID: 15007056
[TBL] [Abstract][Full Text] [Related]
20. A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment.
Liu S; Julian J; Carson DD
J Biol Chem; 1998 Apr; 273(16):9718-26. PubMed ID: 9545307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
